Product Catalog [{"id":"10","name":"Tymlos","price":3220,"sku":"Tymlos (abaloparatide)","brand":"Radius Health, Inc.","position":1,"category":"Medicines\/Rheumatology\/Osteoporosis"}]

Osteoporosis access options

Osteoporosis is a condition characterised by a decrease in bone density, resulting in fragile bones. Bone density decreases after the age of 35, with bone loss occurring more rapidly in women after menopause. Key risk factors include genetics, lack of exercise, lack of calcium and vitamin D, personal history of fracture as an adult, cigarette smoking, excessive alcohol consumption, history of rheumatoid arthritis, low body weight, and a family history of osteoporosis1. Osteoporosis is a silent disease, meaning that it often goes uncovered until bone fracture occurs. Incidence and burden Worldwide, osteoporosis causes more than 8.9 million fractures annually, resulting in an osteoporotic fracture... Read more » every 3 seconds. Osteoporosis is more common in women than men and affects an estimated 200 million women worldwide. Of these women, approximately one-tenth are 60, one-fifth of women are 70, two-fifths are 80 and two-thirds are aged 90. For a list of medicines that have been approved for osteoporosis, please see below. If a medicine has been approved by at least one reputable medical authority in the world but it is not available in your country, you may be able to purchase it via our service; we may be able to source and deliver it to you if you can provide a prescription from your doctor.
  1. Tymlos
    Tymlos (abaloparatide)
View as Grid List

1 Item

Set Descending Direction
Read more about the latest treatments in Osteoporosis
US 0